Literature DB >> 21185169

Frontiers in targeting glioma stem cells.

Guido Frosina1.   

Abstract

Patients with glioblastoma multiforme (GBM - WHO grade IV) seldom recover. This is due to the infiltrative nature of these tumours and the presence of cellular populations with ability to escape therapies and drive tumour recurrence and progression. In some cases, these resistant cells exhibit stem properties [glioma stem cells (GSC)]. This article aims at discussing relevant issues on GSC resistance to current therapies and outlines possible and promising avenues in regard to novel therapeutic strategies, such as pharmacological, immunological and viral interventions.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185169     DOI: 10.1016/j.ejca.2010.11.017

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.

Authors:  Enrico Cappelli; Donatella Vecchio; Guido Frosina
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-07       Impact factor: 4.553

2.  Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinases.

Authors:  Marina Bury; Anna Andolfi; Bernard Rogister; Alessio Cimmino; Véronique Mégalizzi; Véronique Mathieu; Olivier Feron; Antonio Evidente; Robert Kiss
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

3.  Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.

Authors:  Tooba A Cheema; Ryuichi Kanai; Geon Woo Kim; Hiroaki Wakimoto; Brent Passer; Samuel D Rabkin; Robert L Martuza
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

4.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

5.  CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.

Authors:  Diana Aguilar-Morante; Jose A Morales-Garcia; Angel Santos; Ana Perez-Castillo
Journal:  Oncotarget       Date:  2015-02-28

6.  Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells.

Authors:  Weiguo Li; Pengfei Jiang; Xiaoling Sun; Shujun Xu; Xiangyu Ma; Rucai Zhan
Journal:  Cell Mol Neurobiol       Date:  2016-03-16       Impact factor: 5.046

Review 7.  Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma.

Authors:  Laura Annovazzi; Marta Mellai; Davide Schiffer
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

8.  TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.

Authors:  Bo Qiu; Xiyang Sun; Dongyong Zhang; Yong Wang; Jun Tao; Shaowu Ou
Journal:  Int J Mol Sci       Date:  2012-07-20       Impact factor: 6.208

9.  Cancer Stem Cells in Glioblastoma Multiforme.

Authors:  Amy Bradshaw; Agadha Wickremesekera; Helen D Brasch; Alice M Chibnall; Paul F Davis; Swee T Tan; Tinte Itinteang
Journal:  Front Surg       Date:  2016-08-26

Review 10.  Long Non-Coding RNAs Dysregulation and Function in Glioblastoma Stem Cells.

Authors:  Xiaoqin Zhang; Karrie Meiyee Kiang; Grace Pingde Zhang; Gilberto Kakit Leung
Journal:  Noncoding RNA       Date:  2015-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.